Who are the Top People in Radiology 2016?
Diagnostic Imaging’s annual Top People in Radiology contest is getting a new spin. This year, the contest will feature two categories: Rising Star and Lifetime Achievement.
Entrants must be U.S.-based and currently employed by or working in the radiology profession, including but not limited to physician, nurse, administrator, technologist, or researcher. Other applicable titles within the profession will also be considered.
Rising Stars must have begun practicing in the radiology profession in the last 10 years.
Lifetime Achievement nominees must be a 30+ year veteran of the radiology profession.
All nominees should exhibit outstanding potential or contribution to the field.[[{"type":"media","view_mode":"media_crop","fid":"52261","attributes":{"alt":"Top People in Radiology 2016","class":"media-image media-image-right","id":"media_crop_9104135537735","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6491","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right; height: 93px; width: 100px; border-width: 0px; border-style: solid; margin: 1px;","title":" ","typeof":"foaf:Image"}}]]
Nominations must be made via SurveyMonkey submission.
Readers who nominate someone will be entered to win a drawing for a $100 gift card. Winners will be selected by committee made up of Diagnostic Imaging editorial board members.
Contest rules are available here.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.